Qilu Antibiotics Pharmaceutical Co., Ltd.

Qilu Antibiotics Pharmaceutical Co., Ltd.

Established in 1995, Qilu Antibiotics focused on manufacturing of cephalosporin APIs, cephalosporin finished products and Carbapenem finished products which covers four product series, such as sterile APIs, oral APIs, pharmaceutical intermediates and finished products. The company has launched 33 varieties of APIs and 32 varieties of finished products to the market. At present, it is one of the manufacturers of cephalosporin APIs with the largest production scale and the most complete cephalosporin products in China. With advanced production system and quality system, the company has successfully passed the official certification of many countries such as: China, the United States, the European Union, Japan and Australia. Up to now, there are totally 23 EU CEP certificates for cephalosporin APIs in China, of which Anti possess 19.

Based on the high-quality development and manufacturing of cephalosporin products, Qilu Anti’s products are exported to more than 80 countries and regions such as Europe, US, Japan, South Korea, and Southeast Asia, etc. It has won the "Top 100 Industrial Enterprises with comprehensive Strength in China's chemical and pharmaceutical Industry" for 9 consecutive years. Won the "China Chemical pharmaceutical industry API export excellent enterprise brand", "China Chemical pharmaceutical industry API Excellent product brand", and won the 2021 USP standard product Special Contribution Award, fully demonstrating the company's industry strength.

Producing one generation, developing one generation and reserving one generation

Anti undertakes more than 30 science and technology projects at all levels in Shandong Province and Jinan City

Adhered to the innovation-driven strategy, Qilu Anti has undertaken more than 30 science and technology projects at all levels in Shandong Province and Jinan City, and 1 major science and technology project in Jinan City. The company was awarded the "National high-tech Enterprise", "Shandong Province recognized Enterprise Technology Center", " Shandong Province high-tech Enterprise innovation Top 100", and won the first prize of Jinan City Science and Technology Progress Award for one project, and third prize for several projects; Won the first prize of Shandong Province Enterprise Technology Innovation Award and the first prize of the second Shandong Province Science and Technology Workers Innovation Competition. The company has obtained 33 authorized patents, and 25 national invention patents are currently valid. The company has developed and researched more than 30 kinds of products, forming a virtuous cycle of product research and development of "producing one generation, developing one generation, reserving one generation".

Always pursue for green development

The company always stick to the strategy of green development and high-quality industrial development.

Stick to the green development and high-quality industrial development strategy, with the green production concept and the industry's advanced equipment and technology, Qilu Anti has won the "China Chemical Pharmaceutical Industry Environmental Protection, Green Pharmaceutical Special Award" for three consecutive years from 2018 to 2020, the LEED V4 Gold Certificate issued by the USGBC, and National "green factory" etc. The company’s 7th construction project was awarded the "2017 Sino-US Contract Energy Management Demonstration Project" with an outstanding performance of annual energy saving of 15% ~ 25%.

Anti's steady development over the years has also received the attention and recognition from the government and society. The company won the "National double outstanding enterprise", "Shandong Youth Civilization", "Shandong Innovative Enterprise", "Shandong Manufacturing individual champion enterprise", "Shandong Manufacturing 100 high-end brand cultivation enterprise", "Shandong pharmaceutical industry quality top 30 enterprises", "Shandong health enterprise", "Jinan May 1st Labor Award", "Jinan Mayor Quality Award" etc. The company's product Ceftazidime was identified as "Shandong Quality Brand" and "Shandong Well-known Brand", which highlights the company's excellent performance management.

The highest realm breeds the magnificent scenery

Pursue a healthier world with all our heart. Qilu Antibiotics wish to create glory together with you.

In 2020, Anti's finished drug product Park project completed and came into operation. The industry-leading API advantage is certainly leading to the rapid development of the finished drug product field. Anti’s finished drug product Park is designed and constructed with the industrial 4.0 architecture, with lean, digital and intelligent features, so that the production and manufacturing of the finished drug product park has entered a new stage of industrial intelligence. The completion of the project marks that Anti has two product series: cephalosporin and Carbapenem products, through the complete industrial chain from raw materials to finished drug product, and with new kinetic energy, Anti is constantly forging ahead toward the goal of doing better, stronger and bigger.